Status:

COMPLETED

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone

Lead Sponsor:

Tehran University of Medical Sciences

Conditions:

Pemphigus Vulgaris

Eligibility:

All Genders

10-75 years

Phase:

PHASE2

Brief Summary

Description: Pemphigus vulgaris is an autoimmune, chronic and recurrent blistering disease with unknown etiology that affects mucosa and skin of patients with significant morbidity and mortality. The...

Detailed Description

The purpose of this trial is to compare efficacy and safety of azathioprine vs. placebo in new cases of pemphigus vulgaris treated with prednisolone. Official Title: Randomized, Double-Blind, Placebo...

Eligibility Criteria

Inclusion

  • Lesions clinically consistent with pemphigus vulgaris
  • Diagnosis confirmed by histology in terms of acantholysis within past month
  • Positive DIF

Exclusion

  • Any nursing or pregnant woman
  • Any history of chronic diseases including liver disease, Chronic Renal Failure, Chronic Heart Failure or Ischemic Heart Disease
  • Present diagnosis of hepatitis confirmed by serology or elevated hepatic enzymes;
  • Clinically significant concurrent medical disease or laboratory abnormalities evidenced by one or more of the following:
  • Hepatobiliary AST or ALT ≥ 1.5 × upper limit of normal (ULN);alkaline phosphatase ≥ 1.5 × ULN; or, total bilirubin \> 90% of the ULN;
  • Renal serum creatinine \> 1.5 mg/dL; or, significant proteinuria \> 2+ on urinary dip test;
  • Hematologic hemoglobin \< 11 mg/dL; leukocytes \< 3.5 × 109/L; neutrophils \< 1.5 × 109/L; or, platelets \< 100 × 109/L; Presence of anemia, leukopenia or thrombocytopenia
  • Any sign of patient's non-compliance
  • Known hypersensitivity to study drugs, prednisone or azathioprine
  • Participating in another clinical trial at the time of screening and enrollment

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2010

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00626678

Start Date

January 1 2008

End Date

September 1 2010

Last Update

November 30 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Dermatology, Tehran University of Medical Sciences

Tehran, Tehran Province, Iran